| |
| |
|
| Insider
Information: |
Hunt Hazel |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
93,354 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,128,471 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
93,354 |
|
|
| Total
Value |
$2,128,471 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-01-08 |
93,354 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2024-01-08 |
4 |
D |
$27.46 |
$818,088 |
D/D |
(29,792) |
93,354 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2024-01-08 |
4 |
OE |
$3.02 |
$151,000 |
D/D |
50,000 |
123,146 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-08-14 |
4 |
S |
$30.89 |
$631,753 |
D/D |
(20,455) |
73,146 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-08-08 |
4 |
D |
$30.48 |
$900,532 |
D/D |
(29,545) |
93,601 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-08-08 |
4 |
OE |
$3.02 |
$151,000 |
D/D |
50,000 |
123,146 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-09-28 |
4 |
D |
$26.04 |
$781,122 |
D/D |
(29,997) |
73,146 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-09-28 |
4 |
OE |
$2.08 |
$104,000 |
D/D |
50,000 |
103,143 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-01-26 |
4 |
D |
$17.16 |
$435,006 |
D/D |
(25,350) |
53,143 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2022-01-26 |
4 |
OE |
$3.32 |
$132,800 |
D/D |
40,000 |
78,493 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-07-14 |
4 |
D |
$20.59 |
$627,624 |
D/D |
(30,482) |
38,493 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-07-14 |
4 |
OE |
$2.89 |
$144,500 |
D/D |
50,000 |
68,975 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-11-24 |
4 |
D |
$22.88 |
$714,428 |
D/D |
(31,225) |
18,975 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-11-24 |
4 |
OE |
$3.96 |
$198,000 |
D/D |
50,000 |
50,200 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Scientific OfficerOffice |
• – – |
2020-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200 |
|
% |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
